1 / 7

Lapahope 250mg tablet - Lapatinib | Myapplepharma

Lapahope 250mg tablets are classified as anti-cancer agent, which is orally active drug used for treating breast cancer, Chemically classified as quinazoline with strong anti-cancer effect.<br>

savanah
Download Presentation

Lapahope 250mg tablet - Lapatinib | Myapplepharma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Myapplepharma Lapahope 250mg

  2. Lapahope tablets are classified as anti-cancer agent, which is orally active drug used for treating breast cancer.Chemically classified as quinazoline with strong anti-cancer effect and the tablet Lapahope is a synthetic oral tablet.Normally targeted therapy or tyrosine kinase inhibitor drugs can increase the plasma amino transferase levels which may leads to liver injury. Description

  3. Indication Primarily Lapahope indicated for advanced breast cancer.Lapahope is indicated for the combination with Capecitabine tablets are normally indicated for the treatment of metastatic breast cancer patients in whose cancer cells expressed with EGFR 2 (HER2) and already patients may get an anthracycline, taxane & Trastuzumab.

  4. Reduction in left ventricular ejection fraction:While using Lapahope in patient with LVEF Caution should be takenThe resentment of LVEF should be decreased within first 12 weeks of treatmentBefore starting the therapy with Lapahope, patient must be monitor thoroughly if suspected with LVEF or not. PRECAUTION

  5. Liver damage:Raising level of AST, ALT or bilirubin may cause liver injuryTo inhibits this condition, periodic LFT should be control. Diarrhea: Serious diarrhea may cause to dehydration leads death also; if patient do not recover from this severity must stop with this therapy. PRECAUTION

  6. LACTATION Breast feeding should not be allowedIn pediatric patients the potency of Lapahope has not been evaluated.While using this medication the patients In both renal & hepatic impairment, then caution should be taken

  7. For More Information Call Us : +91-9987711567 Mail to : applepharmaceutical@gmail.com Domain :https://myapplepharma.com/lapahope-250mg.php

More Related